Norges Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.1M | Buy |
+207,389
| New | +$13.1M | ﹤0.01% | 1242 |
|
2025
Q1 | – | Sell |
-205,649
| Closed | -$11.5M | – | 1353 |
|
2024
Q4 | $11.5M | Buy |
+205,649
| New | +$11.5M | ﹤0.01% | 1333 |
|
2024
Q3 | – | Sell |
-43,238
| Closed | -$1.78M | – | 1418 |
|
2024
Q2 | $1.78M | Sell |
43,238
-7,632
| -15% | -$313K | ﹤0.01% | 1739 |
|
2024
Q1 | $2.2M | Buy |
+50,870
| New | +$2.2M | ﹤0.01% | 1727 |
|
2022
Q1 | – | Sell |
-51,161
| Closed | -$511K | – | 2224 |
|
2021
Q4 | $511K | Hold |
51,161
| – | – | ﹤0.01% | 2149 |
|
2021
Q3 | $668K | Hold |
51,161
| – | – | ﹤0.01% | 2183 |
|
2021
Q2 | $1M | Sell |
51,161
-13,947
| -21% | -$273K | ﹤0.01% | 2117 |
|
2021
Q1 | $1.39M | Sell |
65,108
-94,320
| -59% | -$2.01M | ﹤0.01% | 2025 |
|
2020
Q4 | $4.74M | Hold |
159,428
| – | – | ﹤0.01% | 1878 |
|
2020
Q3 | $3.46M | Sell |
159,428
-70,767
| -31% | -$1.53M | ﹤0.01% | 1915 |
|
2020
Q2 | $5.13M | Hold |
230,195
| – | – | ﹤0.01% | 1860 |
|
2020
Q1 | $3.5M | Hold |
230,195
| – | – | ﹤0.01% | 1872 |
|
2019
Q4 | $5.29M | Buy |
+230,195
| New | +$5.29M | ﹤0.01% | 1906 |
|
2018
Q3 | – | Sell |
-30,000
| Closed | -$938K | – | 2157 |
|
2018
Q2 | $938K | Sell |
30,000
-20,000
| -40% | -$625K | ﹤0.01% | 2073 |
|
2018
Q1 | $995K | Hold |
50,000
| – | – | ﹤0.01% | 2061 |
|
2017
Q4 | $1.45M | Buy |
+50,000
| New | +$1.45M | ﹤0.01% | 2015 |
|